APA
Siegel D. S., Martin T., Wang M., Vij R., Jakubowiak A. J., Lonial S., Trudel S., Kukreti V., Bahlis N., Alsina M., Chanan-Khan A., Buadi F., Reu F. J., Somlo G., Zonder J., Song K., Stewart A. K., Stadtmauer E., Kunkel L., Wear S., Wong A. F., Orlowski R. Z. & Jagannath S. (20121218). A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma. : Blood.
Chicago
Siegel David S, Martin Thomas, Wang Michael, Vij Ravi, Jakubowiak Andrzej J, Lonial Sagar, Trudel Suzanne, Kukreti Vishal, Bahlis Nizar, Alsina Melissa, Chanan-Khan Asher, Buadi Francis, Reu Frederic J, Somlo George, Zonder Jeffrey, Song Kevin, Stewart A Keith, Stadtmauer Edward, Kunkel Lori, Wear Sandra, Wong Alvin F, Orlowski Robert Z and Jagannath Sundar. 20121218. A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma. : Blood.
Harvard
Siegel D. S., Martin T., Wang M., Vij R., Jakubowiak A. J., Lonial S., Trudel S., Kukreti V., Bahlis N., Alsina M., Chanan-Khan A., Buadi F., Reu F. J., Somlo G., Zonder J., Song K., Stewart A. K., Stadtmauer E., Kunkel L., Wear S., Wong A. F., Orlowski R. Z. and Jagannath S. (20121218). A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma. : Blood.
MLA
Siegel David S, Martin Thomas, Wang Michael, Vij Ravi, Jakubowiak Andrzej J, Lonial Sagar, Trudel Suzanne, Kukreti Vishal, Bahlis Nizar, Alsina Melissa, Chanan-Khan Asher, Buadi Francis, Reu Frederic J, Somlo George, Zonder Jeffrey, Song Kevin, Stewart A Keith, Stadtmauer Edward, Kunkel Lori, Wear Sandra, Wong Alvin F, Orlowski Robert Z and Jagannath Sundar. A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma. : Blood. 20121218.